Our most relevant finding is that the imbalance of Th17 and B cells numbers and a lower expression of TLR2 in monocytes along with cyclophosphamide use are the major risk factors for infection in SLE patients. This evidence concerns the gene TLR2 and systemic lupus erythematosus.